Association of low vitamin B12 levels with depressive and schizophrenia spectrum disorders in child and adolescent psychiatric inpatients
- PMID: 40100400
- PMCID: PMC12507942
- DOI: 10.1007/s00787-025-02662-4
Association of low vitamin B12 levels with depressive and schizophrenia spectrum disorders in child and adolescent psychiatric inpatients
Abstract
Folate and vitamin B12 are associated with neurodevelopment and neurotransmitter synthesis and insufficiencies of these nutrients could be linked to psychiatric disorders in children and adolescents. To assess serum levels of folate and B12 in child and adolescent psychiatric inpatients and examine possible links between these levels and different psychiatric disorders. Child and adolescent psychiatric inpatients admitted in a general hospital during a 3-year period were included for analysis. Folate and B12 levels were measured when the subjects were admitted. Psychiatric diagnoses were made following DSM-5 criteria and grouped into categories. Logistic regression analysis was used to study the effects of socio-demographic variables as well as folate and B12 levels, insufficiencies and deficits as possible predictors of outcome (psychiatric diagnostic category). 729 inpatients (60.6% female, mean age: 15.1 ± 2 years) were included. A total of 42.9% presented insufficient folate levels and 19.4% insufficient B12 levels. Insufficient B12 levels were associated with depressive disorders in the multivariate model (OR = 0.82, p = 0.002) as was female sex (OR = 1.65, p = 0.007). Moreover, low vitamin B12 levels were linked to schizophrenia spectrum disorders (SSD, OR = 0.9982, p = 0.024). In contrast, higher folate (OR = 1.15, p < 0.001) and vitamin B12 levels (1.0024, p = 0.002) as well as female sex (OR = 7.86, p < 0.001) were associated with eating disorders. Insufficient or low B12 levels could help predict depressive and SSD respectively in child and adolescent psychiatric inpatients. Further study could help us better understand the impact of this insufficiency during the neurodevelopmental period and the potential benefits of nutritional interventions.
Keywords: Child and adolescent; Cobalamin; Depression; Folate; Psychiatry; Vitamin.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: GA has received CME-related honoraria, or consulting fees from Janssen-Cilag, Lundbeck and Angelini with no financial or other relationship relevant to the subject of this article. EV has received honoraria and travel support from Otsuka-Lundbeck, Shire and Janssen. AG-P has received support from Janssen-Cilag and Otsuka-Lundbeck, and declares no support related to the subject of this article. LE has received support from Janssen-Cilag and Otsuka-Lundbeck, and declares no support related to the subject of this article. NP has received grants, personal fees and/or non-financial support from Janssen-Cilag and Otsuka and reports no financial or other relationship relevant to the subject of this article. MS was a grant-holder from Fundación Alicia Koplowitz. IB has received honoraria or travel support from Otsuka-Lundbeck and Angelini, research support from Fundación Alicia Koplowitz and grants from Spanish Ministry of Health, Instituto de Salud Carlos III (PI18/00242, PI21/00391) and National Drugs Plan (2022I053). All other authors declare no conflicts of interest relevant to the subject of this article.
Figures
References
-
- González HF, Visentin S (2016) Micronutrients and neurodevelopment: an update (. ArchArgent Pediatr 114:570–575. 10.5546/aap.2016.eng.570 - PubMed
-
- Sudfeld CR, Charles McCoy D, Danaei G et al (2015) Linear Growth and Child Development in Low- and Middle-Income countries: a Meta-analysis. Pediatrics 135:e1266–e1275. 10.1542/peds.2014-3111 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
